3g8i

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: '''Unreleased structure''' The entry 3g8i is ON HOLD Authors: Benardeau, A. et al Description: Aleglitazar, a new, potent, and balanced PPAR alpha/gamma agonist for the treatment of ty...)
Line 3: Line 3:
The entry 3g8i is ON HOLD
The entry 3g8i is ON HOLD
-
Authors: Benardeau, A. et al
+
Authors: Benz, J., Bernardeau, A., Binggeli, A., Blum, D., Boehringer , M., Grether, U., Hilpert, H., Kuhn, B., Maerki, H.P., Meyer, M., Puentener, K., Raab, S., Ruf, A., Schlatter, D., Gsell, B., Stihle, M., Mohr, P.
Description: Aleglitazar, a new, potent, and balanced PPAR alpha/gamma agonist for the treatment of type II diabetes
Description: Aleglitazar, a new, potent, and balanced PPAR alpha/gamma agonist for the treatment of type II diabetes
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Feb 25 09:27:56 2009''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Mar 4 14:45:01 2009''

Revision as of 12:45, 4 March 2009

Unreleased structure

The entry 3g8i is ON HOLD

Authors: Benz, J., Bernardeau, A., Binggeli, A., Blum, D., Boehringer , M., Grether, U., Hilpert, H., Kuhn, B., Maerki, H.P., Meyer, M., Puentener, K., Raab, S., Ruf, A., Schlatter, D., Gsell, B., Stihle, M., Mohr, P.

Description: Aleglitazar, a new, potent, and balanced PPAR alpha/gamma agonist for the treatment of type II diabetes

Page seeded by OCA on Wed Mar 4 14:45:01 2009

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools